This has been achieved with non-dilutive capital and provides significant opportunity for HeartSciences to hit a number of valuable commercial milestones.” About HeartSciences Heart Test ...
Andrew Simpson, CEO of HeartSciences, said, “We have extended our capital runway by $2.4 million since late August ahead of our upcoming FDA submissions. This has been achieved with non-dilutive ...